IPAD-DB ID | C00432 |
Name | Moracin D |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 9 H 1 6 O 4 |
Molecular Weight | 308.3g/mol |
IUPAC Name | 7-(6-hydroxy-1-benzofuran-2-yl)-2, 2-dimethylchromen-5-ol |
InChI | InChI=1S/C19H16O4/c1-19(2)6-5-14-15(21)7-12(9-18(14)23-19)16-8-11-3-4-13(20)10-17(11)22-16/h3-10, 20-21H, 1-2H3 |
InChIKey | CHAAQDMHLLQJRO-UHFFFAOYSA-N |
Canonical SMILES | CC1(C=CC2=C(C=C(C=C2O1)C3=CC4=C(O3)C=C(C=C4)O)O)C |
PubChem CID | 641378 |
DrugBank Accession Number | - |
CAS Registry Number | 69120-07-6 |
Molecular Weight(Computed by SwissADME) | 308.33 |
Hac(Computed by SwissADME) | 23 |
Volume(Computed by ADMETlab 2.0) | 317.024 |
Density(Computed by ADMETlab 2.0) | 0.972 |
nRing(Computed by ADMETlab 2.0) | 4 |
MaxRing(Computed by ADMETlab 2.0) | 10 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 21 |
Flexibility(Computed by ADMETlab 2.0) | 0.048 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.202 |
LogD(Computed by ADMETlab 2.0) | 3.945 |
logP(Computed by ADMETlab 2.0) | 4.7 |
TPSA(Computed by SwissADME) | 62.83 Ų |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 1 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.20 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | Yes |
Bioavailability Score(Computed by SwissADME) | 0.55 |